Menu
Back to Journals » Drug Design, Development and Therapy » Volume 19
Population Pharmacokinetic of Epidural Sufentanil in Labouring Women: A Multicentric, Prospective, Observational Study [Corrigendum]
Nie Y, Sun X, Cao R, et al. Drug Des Devel Ther. 2025(19): 971-980.
Upon receiving the letter to the editor addressing the dosage error, we hereby correct the dosage from 3 μg/mL sufentanil mixture to 0.3 μg/mL sufentanil mixture for accuracy.
In “Materials and Methods”, “Anesthesia Management” subsection on page 972, second sentence should read from “After placing an indwelling epidural catheter as a routine procedure, the mother was given an epidural injection of 0.1% ropivacaine and 3μg/mL sufentanil mixture”. To “After placing an indwelling epidural catheter as a routine procedure, the mother was given an epidural injection of 0.1% ropivacaine and 0.3μg/mL sufentanil mixture”.
The authors apologize for this oversight.
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.